listing

NYSE Content Advisory: Pre-Market update + KPMG hosts IPO Bootcamp at NYSE

NEW YORK, June 9, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

4 months ago

AB Anywhere: Why List on Binance Alpha?

SINGAPORE, June 7, 2025 /PRNewswire/ -- On June 7, 2025, AB DAO announced that its native token $AB officially began trading…

4 months ago

AB Anywhere: $AB Goes Live on Binance, Ushering in a New Era of Cross-Chain Asset Mobility

DUBLIN, June 7, 2025 /PRNewswire/ -- On June 7, 2025 at 14:00 (UTC+8), AB DAO announced that its native token…

4 months ago

NYSE Content Advisory: Pre-Market update + Circle shares surge in first day of trading

NEW YORK, June 6, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

4 months ago

Semilux Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 20-F

June 02, 2025 19:30 ET  | Source: Semilux International Ltd. Taipei, Taiwan, June 02, 2025 (GLOBE NEWSWIRE) -- Semilux International…

5 months ago

NYSE Content Advisory: Pre-Market update + U.S. – China trade tensions escalate

NEW YORK, June 2, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

5 months ago

Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]

Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE WYOST® (denosumab-bbdz) and Jubbonti® (denosumab-bbdz) are first…

5 months ago

Celularity Receives Nasdaq Notice Regarding Form 10-Q

May 30, 2025 17:30 ET  | Source: Celularity Inc. FLORHAM PARK, N.J., May 30, 2025 (GLOBE NEWSWIRE) -- Celularity Inc.…

5 months ago